Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Bazedoxifene 20 mg
DRUG
4 trials
Sponsors
Pfizer
, Hyundai Pharmaceutical Co., LTD.
, Alvogen Korea
, Hôpital Fribourgeois
Conditions
Healthy
Menopause
Osteoporosis
Pancreas Cancer
Phase 1
HDDO-1614 Intervention Trial
Completed
NCT03234244
Hyundai Pharmaceutical Co., LTD.
Osteoporosis
Start: 2017-04-12
End: 2017-08-14
Updated: 2017-12-11
AK-R215 Pharmacokinetic Study Phase I
NCT03321318
Alvogen Korea
Healthy
Start: 2017-07-13
End: 2018-01-12
Target: 52
Updated: 2017-10-25
Phase 3
Study Evaluating The Effects Of Bazedoxifene/Conjugated Estrogens On Endometrial Safety And Postmenopausal Osteoporosis
Completed
NCT00808132
Pfizer
Menopause, Osteoporosis
Start: 2009-01-31
End: 2011-02-28
Updated: 2014-04-08
Unknown Phase
Bazedoxifene as a Concomitant Treatment of Patients With Metastatic Pancreatic Adenocarcinoma
NCT04812808
Hôpital Fribourgeois
Pancreas Cancer
Start: 2022-02-01
End: 2024-05-31
Target: 10
Updated: 2022-02-25
Related Papers
Breast effects of bazedoxifene-conjugated estrogens: a randomized controlled trial.
2013-05-01
80 citations